GlassScriptPhysician profile
Penny J Milligan
NPI 1184974032
$2,445.59
in general payments reported to CMS, 2019-2025
21 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $113 · 2022: $464 · 2023: $434 · 2024: $435 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,844 · Grant: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,844.42 |
| Grant | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $608.33 | 2022-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Gallant |
| Novartis Pharmaceuticals Corporation | $231.56 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $194.75 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $194.27 | 2022-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $156.67 | 2021-2025 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $130.45 | 2025 | |
| Teleflex LLC | $128.71 | 2022-2023 | Supercross, Trapliner |
| Penumbra, INC. | $126.81 | 2025 | Indigo System |
| Bridgebio Pharma, INC. | $125.87 | 2025 | Attruby |
| Abiomed | $115.02 | 2023 | Impella |
| Boston Scientific Corporation | $100.77 | 2021-2025 | Watchman Flx, Watchman Access System |
| Kestra Medical Technology Services, INC. | $86.43 | 2025 | Assure Wcd |
| Pfizer INC. | $72.73 | 2023-2024 | |
| Atricure, INC. | $31.43 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $26.90 | 2021-2024 | Eliquis |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $25.00 | 2025 | |
| Biosense Webster, INC. | $22.22 | 2022 | |
| Amgen INC. | $20.75 | 2024 | Repatha |
| Novo Nordisk INC | $18.85 | 2023 | Ozempic, Rybelsus |
| Terumo Medical Corporation | $16.28 | 2025 | Optitorque |
| Medtronic, INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Penny Milligan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.